United Therapeutics buy Royal Bank of Canada
Start price
30.10.25
/
50%
€388.80
Target price
30.10.26
-
Performance (%)
28.65%
Price
17.04.26
€500.20
Summary
This prediction is currently active. The prediction currently has a performance of 28.65%. This prediction currently runs until 30.10.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | 2.647% | 2.647% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (NASDAQ:UTHR) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€426.90
26.02.26
26.02.26
€544.04
26.02.27
26.02.27
17.17%
17.04.26
17.04.26
United Therapeutics
Start price
Target price
Perf. (%)
€364.40
26.09.25
26.09.25
€487.63
26.09.26
26.09.26
37.27%
17.04.26
17.04.26